<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04831086</url>
  </required_header>
  <id_info>
    <org_study_id>OPTIM-PTL</org_study_id>
    <nct_id>NCT04831086</nct_id>
  </id_info>
  <brief_title>To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis</brief_title>
  <acronym>OPTIM-PTL</acronym>
  <official_title>To Optimize Antenatal Management of Women Admitted With Pre Term Labor and Intact Membranes Using Multivariable Prediction Models: Multicenter Randomised Control Trial (OPTIM-PTL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Clinic per a la Recerca Biomédica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Vall d'Hebron</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario 12 de Octubre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Consorci Sanitari de Terrassa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Puerta del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sant Joan de Deu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion Clinic per a la Recerca Biomédica</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Implementation of prediction models of risk of spontaneous delivery within 7 days or of&#xD;
      intra-amniotic infection in women with preterm labor and intact membranes&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate whether the implementation of prediction models of risk of spontaneous delivery&#xD;
      within 7 days or of intra-amniotic infection:&#xD;
&#xD;
        1. Optimises antenatal management (regarding steroids, tocolysis, antibiotics, maternal&#xD;
           length stay duration) without worsening perinatal outcomes.&#xD;
&#xD;
        2. It is a cost-effective strategy.&#xD;
&#xD;
        3. It improves neonatal outcome (in premature newborns &lt;30 weeks), and reduces infectious&#xD;
           maternal morbility.&#xD;
&#xD;
        4. It improves neurodevelopmental outcome at 1.2 and 5 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 5, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pregnant women with singleton pregnancies admitted with a diagnosis of preterm labor and intact membranes between 23.0 and 34.6 weeks, not in labor at randomization and who do not meet exclusion criteria.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antenatal steroid doses</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Number of antenatal steroid doses administered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>maternal stay length</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Maternal length of hospital stay (in days).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical chorioamnionitis</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Clinical chorioamnionitis occurrence defined by the presence of maternal fever &gt;=38ºC, fetal tachycardia &gt; 160 bpm, leukocytes &gt; 14000/m2 without steroids effect and cervical purulent fluid</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Tocolysis duration</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Tocolysis duration (in days)</description>
  </other_outcome>
  <other_outcome>
    <measure>Gestational age at delivery</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Gestational age at delivery</description>
  </other_outcome>
  <other_outcome>
    <measure>Spontaneous delivery within 7 days after admission</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Spontaneous delivery within 7 days after admission (yes/no),</description>
  </other_outcome>
  <other_outcome>
    <measure>Microbial invasion of amniotic cavity</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Microbial invasion of amniotic cavity (yes/no) defined by the presence of a positive amniotic fluid culture, detection of 16S rRNA gene or visualization of microorganisms at the Gram stain</description>
  </other_outcome>
  <other_outcome>
    <measure>Cost analyses</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Cost analyses: The following resource items will be collected: maternal and neonatal admissions, method of delivery, type of induction, outpatient visits, emergency visits, medication, surgical procedures, maternal stay length.</description>
  </other_outcome>
  <other_outcome>
    <measure>Maternal morbidity</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Maternal morbidity (yes/no) including intrapartum fever, endometritis, infection of surgical wound, sepsis, curettage, admission to ICU, hysterectomy, need for transfusion, maternal death.</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal length of hospital stay</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Neonatal length of hospital stay (days)</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal birthweight (in grams)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Neonatal anthropometric measurements</description>
  </other_outcome>
  <other_outcome>
    <measure>height (in centimeters)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Neonatal anthropometric measurements</description>
  </other_outcome>
  <other_outcome>
    <measure>cephalic, thoracic and abdominal perimeters (in millimeters)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Neonatal anthropometric measurements</description>
  </other_outcome>
  <other_outcome>
    <measure>arm circumference (in centimeters)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Neonatal anthropometric measurements</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse neonatal outcome</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>A composite adverse neonatal outcome (yes/no) defined as the presence or one or more of the following outcomes: fetal or neonatal death, early onset sepsis, moderate/severe bronchopulmonary dysplasia, severe intraventricular haemorrhage, periventricular leukomalacia, surgical necrotizing enterocolitis, retinopathy requiring laser treatment.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Preterm Birth</condition>
  <condition>Preterm Labor</condition>
  <condition>Intra-amniotic Infection</condition>
  <condition>Amniocentesis Affecting Fetus or Newborn</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the intervention arm, the management will be optimized according to the risk of the predictive model. The predictive model of intra-amniotic infection includes maternal C-reactive protein (CRP) (in mg/L) and amniotic fluid glucose (in mg/dL), and the predictive model of spontaneous preterm delivery within 7 days includes gestational age (in weeks), cervical length (in mm), amniotic fluid glucose (in mg/dL) and Interleukin (IL)-6 (in a log10 scale). High risk will be defined when the risk is &gt; 10% in the predictive model of spontaneous delivery in 7 days and &gt; 20% in the predictive model of intra-amniotic infection:&#xD;
If low-risk: we will optimize the standard management reducing the dose of steroids (e.g not administering second doses), tocolysis duration and facilitating discharge home.&#xD;
If high-risk: we will follow the standard management of each center and we will treat with antibiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In the control arm the standard management of each center will be followed regarding doses of steroids, duration of tocolysis or maternal stay length duration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroid Drug</intervention_name>
    <description>Steroids doses will be optimized in the intervention group according the risk based on predictive models</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tocolytic Agents</intervention_name>
    <description>Tocolysis duration will be optimized in the intervention group according the risk based on predictive models</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women with singleton pregnancies admitted with a diagnosis of preterm labor&#xD;
             between 23.0 and 34.6 weeks, not in labor at randomization and who do not meet&#xD;
             exclusion criteria.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who do no accept to be part of the study&#xD;
&#xD;
          -  Maternal age &lt; 18 years&#xD;
&#xD;
          -  Multiple gestations&#xD;
&#xD;
          -  Clinical chorioamnionitis at randomization (defined by the presence of fever above 38&#xD;
             celsius degrees (ºC), fetal tachycardia (&gt;160 heart beat per minute &gt;10 minutes),&#xD;
             maternal White blood cells &gt; 15000/mm3 (not justified by the administration of&#xD;
             antenatal steroids).&#xD;
&#xD;
          -  Cervical dilatation &gt; 3 cm&#xD;
&#xD;
          -  Major structural malformations of fetal complications that are related to&#xD;
             neurodevelopmental impairment.&#xD;
&#xD;
          -  Technical problems to perform an amniocentesis (prediction models include information&#xD;
             from amniotic fluid: glucose and IL-6 concentration).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teresa Cobo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Recerca Biomèdica Clínica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Teresa Cobo, MD,PhD</last_name>
    <phone>+34 93 227 54 00</phone>
    <phone_ext>7281</phone_ext>
    <email>tcobo@clinic.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana B Sánchez García, Bsc</last_name>
    <phone>+34 93 227 54 00</phone>
    <phone_ext>7281</phone_ext>
    <email>absanchez@clinic.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fundació Recerca Biomèdica Clínica</name>
      <address>
        <city>Barcelona</city>
        <zip>08828</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Cobo, MD, PhD</last_name>
      <phone>34932275600</phone>
      <email>tcobo@clinic.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>https://doi.org/10.1016/j.ajog.2020.02.049</url>
    <description>Predictive models of spontaneous delivery within 7 days and of intra-amniotic infections description</description>
  </link>
  <results_reference>
    <citation>Cobo T, Aldecoa V, Figueras F, Herranz A, Ferrero S, Izquierdo M, Murillo C, Amoedo R, Rueda C, Bosch J, Martínez-Portilla RJ, Gratacós E, Palacio M. Development and validation of a multivariable prediction model of spontaneous preterm delivery and microbial invasion of the amniotic cavity in women with preterm labor. Am J Obstet Gynecol. 2020 Sep;223(3):421.e1-421.e14. doi: 10.1016/j.ajog.2020.02.049. Epub 2020 Mar 5.</citation>
    <PMID>32147290</PMID>
  </results_reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 24, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion Clinic per a la Recerca Biomédica</investigator_affiliation>
    <investigator_full_name>Teresa Cobo Cobo</investigator_full_name>
    <investigator_title>Senior Specialist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tocolytic Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all collected IPD</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will be available after the end of the study</ipd_time_frame>
    <ipd_access_criteria>https://apps.sjdhospitalbarcelona.org/redcap/</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 17, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/86/NCT04831086/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

